MDT · News · 20261021N

Octopus 4 Product Recall

Medtronic plc · 2026-10-21 · Importance 38 · Surprise 60

The FDA issued a Class II recall covering 3,746 Medtronic biopsy kits. Material deviations affecting optical tracking triggered the recall and affect the company’s medical-surgical portfolio. The reported recall occurred as Medtronic completed the MiniMed separation and reported first-quarter fiscal 2027 revenue of $9.76 billion.